Phosphodiesterase 5 Inhibitors [phsu]
CARDIOVASCULAR [bdsy]
Diseases [dsyn]
Phosphodiesterase-5 [aapp, enzy]
Enzyme [enzy, orch]
Hydrolysis [npop]
degradation [ftcn]
Cyclic GMP [bacs, nnon]
Essential [qlco]
Intracellular Second Messenger [moft]
modulate [spco]
Diverse [qlco]
Biological Processes [phsf]
Living [idcn]
Cells [cell]
inhibitors [chvf]
Phosphodiesterase-5 [aapp, enzy]
sildenafil [orch, phsu]
vardenafil [orch, phsu]
tadalafil [orch, phsu]
Million [qnco]
Men [popg]
treatment [ftcn]
Erectile dysfunction [dsyn]
sildenafil [orch, phsu]
tadalafil [orch, phsu]
Currently [tmco]
Approved [qlco]
treatment [ftcn]
Pulmonary Hypertension [dsyn]
Power [hcpp]
Basic Science [resa]
Clinical Studies [resa]
Suggest [idcn]
applications [hlca]
Phosphodiesterase Type 5 Inhibitors [phsu]
Including [ftcn]
Ischemia-Reperfusion Injury [inpo]
Myocardial Infarction [dsyn]
Cardiac Hypertrophy [patf]
Cardiomyopathy [dsyn]
Heart failure [dsyn]
Stroke [dsyn]
Neurodegenerative Diseases [dsyn]
Circulatory Disorders [dsyn]
Including [ftcn]
Raynaud Phenomenon [dsyn]
Future [tmco]
Controlled Clinical Trial [inpr]
Expanding [spco]
therapeutic use [topp]
Patients [podg]
Cardiovascular disease [dsyn]
